Glucan particle encapsulated rifampicin for targeted delivery to macrophages

Polymers

Volumn 2, Issue 4, 2010, Pages 681-689

  Soto, Ernesto ^a   Kim, Yun Seong ^a,b   Lee, Jinhee ^a   Kornfeld, Hardy ^a   Ostroff, Gary ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Glucan particle; Hydrogel; Macrophage targeted delivery; Rifampicin

Indexed keywords

ANTI-MICROBIAL EFFECTS; AQUEOUS BUFFER; BAKER'S YEAST; BONE MARROW; CALCIUM ALGINATE; CELL UPTAKE; CHITOSAN HYDROGEL; COLONY FORMING UNITS; DRUG RELEASE; GLUCAN PARTICLE; HOLLOW CAVITIES; M. TUBERCULOSIS; MINIMAL INHIBITORY CONCENTRATION; PARTICLE RESUSPENSIONS; PHAGOCYTIC CELLS; POROUS SHELLS; RIFAMPICIN; SACCHAROMYCES CEREVISAE; TARGETED DELIVERY;

ALGINATE; CHITIN; CHITOSAN; MACROPHAGES;

HYDROGELS;

EID: 79952849142     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym2040681     Document Type: Article

References (20)

1. Gursoy, A.; Kut, E.; Ozkirimli, S. Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy. Int. J. Pharm. 2004, 271, 115-123.
2. Yoshida, A.; Matumoto, M.; Hshizume, H.; Oba, Y.; Tomishige, T.; Inagawa, H.; Kohchi, C; Hino, M.; Ito, F.; Tomoda, K.; Nakajima, T.; Makino, K.; Terada, H.; Hori, H.; Soma, G.-I. Selective delivery of rifampicin incorporated into poly(DL-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette-Guerin. Microbes Infect. 2006, 8, 2484-2491.
3. Hirota, K.; Hasegawa, T.; Nakajima, T.; Inagawa, H.; Kohchi, C; Soma, G.-I.; Makino, K.; Terada, H. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J. Controll. Release 2010, 142, 339-346.
4. Pandey, R; Sharma, A.; Zahoor, A.; Sharma, S.; Khuller, G.K.; Prasad, B. Poly(DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J. Antimicrob. Chemother. 2003, 56, 981-986.
5. Kumar, P.V.; Asthana, A.; Dutta, T.; Jain, N.K. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J. Drug Target. 2006. 14, 546-556.
6. Hong, F.; Yan, J.; Baran, J.T.; Allendorf, D.J.; Hansen, R.D.; Ostroff, GR.; Xing, P.X.; Cheung, N.-K.V.; Ross, G.D. Mechanism by which orally administered b-l,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immun. 2004, 173, 797-806.
7. Soto, E.; Ostroff, G.R. Characterization of multilayered nanoparticles inside yeast cell wall particles for DNA delivery. Bioconjugate Chem. 2008, 19, 840-848.
8. Aouadi, M.; Tesz, G.J.; Nicoloro, S.M.; Wang, M.; Chouinard, M.; Soto, E.; Ostroff, GR.; Czech, M.P. Orally delivered siRNA targeting macrophage MAP4K4 supresses systemic inflammation. Nature 2009, 458, 1180-1184.
9. Hoffman, A.S. Hydrogels for biomedical applications. Adv. Drug Del. Rev. 2002, 54, 3-12.
10. Hunt, N.C.; Smith, A.M.; Gbureck, U.; Shelton, R.M.; Grover, L.M. Encapsulation of fibroblasts causes accelerated alginate hydrogel degradation. Acta Biomater. 2010, 6, 3649-3656.
11. Augst, A.D.; Kong, HJ.; Mooney, D.J. Alginate hydrogels as biomaterials. Macromol. Biosci. 2006, 6, 623-633.
12. Jamstorp, E.; Aase, B.; Gatenholm, P.; Jeppsson, A.; Stromme, M. Release of antithrombotic drugs from alginate gel beads. Curr. Drug Del. 2010, 7, 297-302.
13. Bhattarai, N.; Gunn, J.; Zhang, M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Del. Rev. 2010, 62, 83-99.
14. Gomez d'Ayala, G.; Malinconico, M.; Laurienzo, P. Marine derived polysaccharides for biomedical applications: Chemical modification approaches. Molecules 2008, 13, 2069-2106.
15. Prabaharan, M. Chitosan derivatives as promising materials for controlled drug delivery. J. Biomater. Appl. 2008, 23, 5-36.
16. George, M.; Abraham, T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan-A review. J. Control. Release 2006, 114, 1-14.
17. Pym, A.S.; Brodin, P.; Majlessi, L.; Brosch, R.; Demangel, C.; Williams, A.; Griffiths, K.E.; Marchai, G.; Leclerc, C.; Cole, S.T. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 2003, 9, 533-539.
18. Brandt, L.; Feino Cunha, J.; Weinreich Olsen, A.; Chilima, B.; Hirsch, P.; Appelberg, R.; Andersen, P. Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 2002, 70, 672-678.
19. Behr, M.A.; Wilson, M.A.; Gill, W.P.; Salamon, H.; Schoolnik, G.K.; Rane, S.; Small, P.M. Comparative genomics of BCG vaccines by whole genome DNA microarray. Science 1999, 284, 1520-1523.
20. Sambandamurthy, V.K.; Derrick, S.C.; Jalapathy, V.K.; Chen, B.; Russell, R.G.; Morris, S.L; Jacobs, W.R. Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis. Infect. Immun. 2005, 73, 1196-1203.